🇺🇸 FDA

Drug profile · INN

hexocyclium methylsulfate

TRAL

approved
US status
approved
Patents linked
8
News articles
0

Quick answer

hexocyclium methylsulfate (TRAL) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN hexocyclium methylsulfate
Brand TRAL
Route ORAL
Formulation TABLET

Related patents

Search patents →

  1. US 12422364

    Fluorescence spectral shape analysis for analyte recognition

    Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12329457

    Hyperspectral imaging for early detection of Alzheimer's disease

    Expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12331105

    Broadly neutralizing antibodies against HIV

    Expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12274735

    IL-4-fusion formulations for treatment of central nervous system (CNS) tumors

    Expires Mon Apr 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12269872

    Neutralizing antibodies to Plasmodium falciparum circumsporozoite protein and their use

    Expires Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12202886

    Neutralizing antibodies to GP120 and their use

    Expires Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12156912

    Methods and compositions for inhibiting diseases of the central nervous system

    Expires Mon Nov 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12146150

    Rescue of central and peripheral neurological phenotype of friedreich's ataxia by intravenous delivery

    Expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is hexocyclium methylsulfate?

hexocyclium methylsulfate (TRAL) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for hexocyclium methylsulfate?

TRAL is a marketed brand name for hexocyclium methylsulfate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of hexocyclium methylsulfate?

hexocyclium methylsulfate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.